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The relationship between Alzheimer’s disease (AD) and neuroinflammation has become stronger since the 
identification of several genetic risk factors related to microglial function. Though the role of microglial cells in the 
development/progression of AD is still unknown, a dysfunctional response has recently gained support. In this 
sense, we have reported an attenuated microglial activation associated to amyloid plaques in the hippocampus 
of AD patients, including a prominent degenerative process of the microglial population in the dentate gyrus, 
which was in contrast to the exacerbated microglial response in amyloidogenic models. This microglial 
degeneration could compromise their normal role of surveying the brain environment and respond to the 
damage. Here, we have further analyzed the phenotypic profile displayed by the damage-associated microglial 
cells by immunostaining and qPCR  in the hippocampus of postmortem samples of AD patients (Braak V-VI) and 
control cases (Braak 0-II). Damage-associated microglial cells of Braak V-VI individuals were clustered around 
amyloid plaques and expressed Iba1, CD68, Trem2, TMEM119 and CD45high. A subset of these cells also 
expressed ferritin. On the contrary, these microglia down-regulated homeostatic markers, such as Cx3cr1 and 
P2ry12. The homeostatic and ramified microglial cells of non-demented Braak II cases were characterized by 
Iba1, CX3CR1, P2ry12, TMEM119 and CD45low expression. The dynamic of the microglial molecular phenotypes 
associated to AD pathology needs to be considered for better understand the disease complexity and, therefore, 
guarantee clinical success. Correcting dysregulated brain inflammatory responses might be a promising avenue 
to prevent/slow cognitive decline. 
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